VIB News

VIB in brief

VIB is an entrepreneurial non-profit research institute, with a clear focus on groundbreaking strategic basic research in life sciences and operates in close partnership with the five universities in Flanders – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel and Hasselt University.

More info

Innovation and business

Technology transfer is firmly embedded in VIB’s mission. VIB research leads to new and innovative insights into life processes, benefiting society as a whole. Our Innovation & Business team focuses on translating research results into diverse new products, agricultural innovations, medicines and therapies that improve lives.

More info

VIB Research

VIB performs world-leading basic research on some of the most poignant biological questions of our time. It is VIB’s strong conviction that fundamental scientific research – often guided by serendipity – can result in major, sometimes unforeseen, breakthroughs.

More info

Events

VIB regularly organizes events for both the general public and the research community. From small seminars to large lectures by international speakers, from transferable skill courses to introductions to new research skills, there's always something on the VIB agenda.

More info

Technologies & cores

The basic research performed at VIB pushes the boundaries of scientific knowledge. In doing so, the need for disruptive technologies has become apparent. For this reason, VIB has bundled the technological expertise of the entire institute in a core facilities program to make it available to scientists within and outside of the organization, as well as to industrial partners.

More info

VIB Information brochures

The VIB Facts series is a set of in-depth, science-based informational brochures on topics as diverse as animal testing, crop production, and genome engineering. Every brochure has been curated by experts in the field to provide you with the most up-to-date information.

More info

Remarkable Biotech news

VIB’s newest spin-off, Augustine Therapeutics, aims to develop therapeutics for patients suffering from Charcot-Marie-Tooth disease and other neuromuscular diseases. CMT is the most common inherited peripheral neuropathy, with high unmet medical needs. The newly formed company is rooted in the research of the VIB-KU Leuven labs of Ludo Van Den Bosch, Joris de Wit and Bart De Strooper. These scientific teams uncovered several biological pathways in peripheral neuropathies that represent promising therapeutic targets for CMT, including histone deacetylase 6 (HDAC6).

Read more

Success stories

Research at VIB aims to push the boundaries of scientific knowledge. Science, though, is not separate from society. Quite the opposite: science and society support and advance each other. VIB invests significantly in ensuring the largest possible positive societal impact of its research. Through several initiatives we develop basic research findings into benefits for society, ranging from new therapeutic compounds to crop improvements aimed to guarantee food production in a changing climate.

Read more

Related content

Press contacts

If you need more information about our press releases or if you have other questions, please feel free to contact us.
More

VIB's Mediahub

Download images
More